| |
| |
|
| Insider
Information: |
Kopczynski Casey C. |
| Relationship: |
Chief Scientific Officer |
| City: |
Bedminster |
| State: |
NJ |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
0 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$0 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
0 |
|
|
| Total
Value |
$0 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Aerie Pharmaceuticals Inc |
AERI |
Chief Scientific Officer |
2022-11-21 |
0 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
53 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 3
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| AERI |
Aerie Pharmaceuticals Inc |
Chief Scientific OfficerOffice |
• – – |
2013-10-25 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
143,240 |
|
- |
|
| AERI |
Aerie Pharmaceuticals Inc |
Chief Scientific Officer |
• – – |
2013-10-30 |
4 |
A |
$0.00 |
$0 |
D/D |
18,651 |
161,891 |
0 |
- |
|
| AERI |
Aerie Pharmaceuticals Inc |
Chief Scientific Officer |
• – – |
2015-02-25 |
4 |
A |
$0.00 |
$0 |
D/D |
7,188 |
169,079 |
0 |
- |
|
| AERI |
Aerie Pharmaceuticals Inc |
Chief Scientific Officer |
• – – |
2016-02-24 |
4 |
A |
$0.00 |
$0 |
D/D |
9,000 |
178,079 |
0 |
- |
|
| AERI |
Aerie Pharmaceuticals Inc |
Chief Scientific Officer |
• – – |
2017-02-23 |
4 |
A |
$0.00 |
$0 |
D/D |
4,412 |
186,395 |
0 |
- |
|
| AERI |
Aerie Pharmaceuticals Inc |
Chief Scientific Officer |
• – – |
2018-02-08 |
4 |
A |
$0.00 |
$0 |
D/D |
8,000 |
193,061 |
0 |
- |
|
| AERI |
Aerie Pharmaceuticals Inc |
Chief Scientific Officer |
• – – |
2019-02-07 |
4 |
A |
$0.00 |
$0 |
D/D |
8,000 |
103,743 |
0 |
- |
|
| AERI |
Aerie Pharmaceuticals Inc |
Chief Scientific Officer |
• – – |
2020-02-06 |
4 |
A |
$0.00 |
$0 |
D/D |
10,000 |
228,511 |
0 |
- |
|
| AERI |
Aerie Pharmaceuticals Inc |
Chief Scientific Officer |
• – – |
2021-02-04 |
4 |
A |
$0.00 |
$0 |
D/D |
11,000 |
207,114 |
0 |
- |
|
| AERI |
Aerie Pharmaceuticals Inc |
Chief Scientific Officer |
• – – |
2022-03-18 |
4 |
A |
$0.00 |
$0 |
D/D |
19,015 |
280,244 |
0 |
- |
|
| AERI |
Aerie Pharmaceuticals Inc |
Chief Scientific Officer |
• – – |
2015-06-15 |
5 |
OE |
$0.01 |
$23 |
D/D |
4,596 |
182,675 |
0 |
- |
|
| AERI |
Aerie Pharmaceuticals Inc |
Chief Scientific Officer |
• – – |
2021-02-15 |
4 |
OE |
$0.20 |
$11,888 |
D/D |
60,651 |
265,522 |
0 |
- |
|
| AERI |
Aerie Pharmaceuticals Inc |
Chief Scientific Officer |
• – – |
2018-02-09 |
4 |
OE |
$0.40 |
$1,284 |
D/D |
3,251 |
139,768 |
0 |
- |
|
| AERI |
Aerie Pharmaceuticals Inc |
Chief Scientific Officer |
• – – |
2019-12-03 |
4 |
OE |
$0.41 |
$47,385 |
D/D |
117,000 |
218,511 |
0 |
- |
|
| AERI |
Aerie Pharmaceuticals Inc |
Chief Scientific Officer |
• – – |
2018-05-24 |
4 |
OE |
$5.00 |
$15,000 |
D/D |
3,000 |
194,517 |
0 |
- |
|
| AERI |
Aerie Pharmaceuticals Inc |
Chief Scientific Officer |
• – – |
2022-02-04 |
4 |
D |
$7.05 |
$6,789 |
D/D |
(963) |
263,506 |
0 |
- |
|
| AERI |
Aerie Pharmaceuticals Inc |
Chief Scientific Officer |
• – – |
2022-02-06 |
4 |
D |
$7.05 |
$6,176 |
D/D |
(876) |
262,630 |
0 |
- |
|
| AERI |
Aerie Pharmaceuticals Inc |
Chief Scientific Officer |
• – – |
2022-02-07 |
4 |
D |
$7.24 |
$5,075 |
D/D |
(701) |
261,929 |
0 |
- |
|
| AERI |
Aerie Pharmaceuticals Inc |
Chief Scientific Officer |
• – – |
2022-02-08 |
4 |
D |
$7.33 |
$5,131 |
D/D |
(700) |
261,229 |
0 |
- |
|
| AERI |
Aerie Pharmaceuticals Inc |
Chief Scientific Officer |
• – – |
2020-11-10 |
4 |
AS |
$13.00 |
$94,965 |
D/D |
(7,305) |
218,809 |
0 |
% |
|
| AERI |
Aerie Pharmaceuticals Inc |
Chief Scientific Officer |
• – – |
2020-11-11 |
4 |
AS |
$13.01 |
$295,210 |
D/D |
(22,695) |
196,114 |
0 |
% |
|
| AERI |
Aerie Pharmaceuticals Inc |
Chief Scientific Officer |
• – – |
2022-11-21 |
4 |
D |
$15.25 |
$4,273,721 |
D/D |
(280,244) |
0 |
0 |
- |
|
| AERI |
Aerie Pharmaceuticals Inc |
Chief Scientific Officer |
• – – |
2021-02-23 |
4 |
D |
$15.66 |
$5,136 |
D/D |
(328) |
264,469 |
0 |
- |
|
| AERI |
Aerie Pharmaceuticals Inc |
Chief Scientific Officer |
• – – |
2016-02-25 |
5 |
D |
$16.34 |
$11,307 |
D/D |
(692) |
181,983 |
0 |
- |
|
| AERI |
Aerie Pharmaceuticals Inc |
Chief Scientific Officer |
• – – |
2021-02-15 |
4 |
D |
$16.41 |
$11,897 |
D/D |
(725) |
264,797 |
0 |
- |
|
53 Records found
|
|
Page 1 of 3 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
